ARGYX | MGLMX | ARGYX / MGLMX | |
Total Expense Ratio | 1.17 | 0.94 | 124% |
Annual Report Gross Expense Ratio | 1.17 | 0.95 | 123% |
Fund Existence | 17 years | 10 years | - |
Gain YTD | 3.672 | 0.934 | 393% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 139M | 2.26B | 6% |
Annual Yield % from dividends | 2.23 | 2.60 | 86% |
Returns for 1 year | 5.65 | 2.23 | 254% |
Returns for 3 years | -8.09 | -6.30 | 128% |
Returns for 5 years | 6.56 | 20.84 | 31% |
Returns for 10 years | -10.64 | 17.74 | -60% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTAEX | 12.65 | 0.07 | +0.56% |
Fidelity Advisor Total Intl Equity A | |||
FLIAX | 10.20 | 0.02 | +0.20% |
First Sentier American Listed Infras Ins | |||
PSSPX | 24.58 | 0.01 | +0.04% |
Principal SmallCap S&P 600 Index R5 | |||
DFMAX | 32.89 | -0.03 | -0.09% |
Davidson Multi-Cap Equity A | |||
JFNAX | 62.23 | -0.86 | -1.36% |
Janus Henderson Global Life Sciences A |